Bronchioloalveolar Carcinoma
📧 Sign up to get email alerts when something new happens for Bronchioloalveolar Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel, carboplatin, and bevacizumab with or without Cixutumumab in stage IV or recurrent non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery [Phase 3]
Phase 3 trial evaluating gefitinib after complete surgical removal of stage IB to IIIA non-small cell lung cancer; results were posted in 20…
-
CLINICAL_TRIALS research · 2014-09-12Clinical Trial Update: Telomere Biology in Early Adenocarcinoma of the Lung
Clinical trial update on telomere biology in early lung adenocarcinoma sponsored by Meir Medical Center; the trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating erlotinib with radiation therapy and chemotherapy for inoperable Stage III non-small cell lung cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features [Phase 2]
Phase 2 trial of Velcade (bortezomib) in previously treated stage IIIB/IV bronchioloalveolar carcinoma and BAC-featured adenocarcinoma of th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.